What is the primary objective when managing a hematoma in a patient with IV therapy?

When managing a hematoma in a patient receiving IV therapy, the primary objective is to effectively address the bleeding and swelling while ensuring the patient's comfort and safety. Discontinuing the IV access is crucial to prevent further bleeding and complications from the hematoma. Applying ice to the area helps reduce swelling and minimize blood flow to the area, thus controlling the hemorrhage. This cold therapy decreases the metabolic demand and provides analgesia, which is beneficial in the acute phase of managing a hematoma.

After an initial period of ice application, it is appropriate to transition to warm compresses. This method can assist in promoting circulation to the area and aiding in the absorption of the fluid that has pooled due to the hematoma. This step enhances healing and reduces the discomfort associated with the swelling.

In this context, continuing the IV while monitoring the hematoma may not be appropriate because ongoing IV use could exacerbate the hematoma and lead to further complications. Similarly, inserting a new IV line without addressing the hematoma does not prioritize the safety and comfort of the patient, and could lead to additional injury if blood continues to accumulate. Thus, the focus must be on discontinuing the IV, applying ice, followed by warm compresses to effectively manage the hematoma.